Zobrazeno 1 - 9
of 9
pro vyhledávání: '"B. W. Haag"'
Autor:
L. H. Stevens, J. M. Huse, L. T. Micon, D. R. Nelson, B. W. Haag, K. O. Ehrman, D. C. Kay, P. S. Maikranz, G. M. Gaylord, T. L. Roberts, Tim E. Taber, R. S. Dilley, P. B. Brown
Publikováno v:
ASAIO Journal. 41:842-846
The maintenance of adequate hemodialysis vascular access is frequently complicated in the patient with polytetrafluoroethylene (PTFE) A-V hemodialysis grafts by venous anastomotic stenosis. This stenosis is caused by neointimal hyperplasia (NIH), a r
Publikováno v:
Transplantation proceedings. 36(10)
Extravesical ureteroneocystostomy to reestablish urinary tract continuity in renal transplantation has been examined through a meta-analysis of more than 14,000 kidney transplants leading to the finding that stented anastomosis was associated with a
Autor:
T E, Taber, P S, Maikranz, B W, Haag, G M, Gaylord, R S, Dilley, K O, Ehrman, P B, Brown, D R, Nelson, D C, Kay, T L, Roberts
Publikováno v:
ASAIO journal (American Society for Artificial Internal Organs : 1992). 41(4)
The maintenance of adequate hemodialysis vascular access is frequently complicated in the patient with polytetrafluoroethylene (PTFE) A-V hemodialysis grafts by venous anastomotic stenosis. This stenosis is caused by neointimal hyperplasia (NIH), a r
Autor:
J Stuart, B. W. Haag, Christoph E. Broelsch, Andrew J. Aronson, Frank P. Stuart, A. O. Gaber, J. R. Thistlethwaite
Publikováno v:
Transplantation. 43:176-183
The monoclonal antibody, Orthoclone OKT3 (OKT3), has been used with great efficacy in a prospective multicenter trial as therapy for first rejection episodes in cadaveric donor (CD) renal allograft recipients treated with azathioprine (AZA) and predn
Autor:
A O, Gaber, J R, Thistlethwaite, B W, Haag, J K, Stuart, J T, Mayes, D M, Lloyd, S, Fellner, F P, Stuart
Publikováno v:
The American surgeon. 53(7)
With the introduction of more potent immunosuppressive regimens, increasing numbers of kidney transplant recipients traditionally viewed as being at high immunologic risk for rejection and graft loss have been accepted. These include recipients of mu
Autor:
D A, Rouch, B W, Haag, C, Gilmore, J M, Careskey, M P, Bubb, B G, Sperl, V Z, Ameen, G T, Chua, D J, Polacek, T M, Williams
Publikováno v:
Indiana medicine : the journal of the Indiana State Medical Association. 82(1)
A multidisciplinary approach is necessary in addressing the needs of a patient with end-stage liver disease. The development of the liver transplant program at MHI was a natural extension of the transplant and critical care programs already in place.
Autor:
A O, Gaber, H C, Yang, B W, Haag, F C, Buckingham, D M, Lloyd, J R, Thistlethwaite, F P, Stuart
Publikováno v:
Transplantation proceedings. 19(1 Pt 2)
Autor:
J R, Thistlethwaite, B W, Haag, A O, Gaber, J K, Stuart, A J, Aronson, J T, Mayes, D M, Lloyd, F P, Stuart
Publikováno v:
Transplantation proceedings. 19(1 Pt 3)
Publikováno v:
Transplantation proceedings. 19(1 Pt 3)